MicroRNA-155通过P2X7R激活NLRP3炎性小体促进ApoE-/-小鼠颈动脉粥样硬化斑块的形成
MicroRNA-155 Activates the NLRP3 Inflammasome by Regulating the P2X7R in Carotid Atherosclerotic Plaques of ApoE-/- Mice
DOI: 10.12677/ACM.2020.1010354, PDF,    国家自然科学基金支持
作者: 彭 晴:青岛大学,山东 青岛;尹瑞华, 马爱军, 潘旭东*:青岛大学附属医院神经内科,山东 青岛;朱晓岩:青岛大学附属医院重症医学科,山东 青岛
关键词: 动脉粥样硬化microRNA-155P2X7RNLRP3炎症小体ApoE-/-小鼠Atherosclerosis MicroRNA-155 P2X7R NLRP3 Inflammasome ApoE-/- Mice
摘要: 目的:探索在ApoE−/−小鼠中,microRNA-155 (miR-155)调控NLRP3炎症小体参与其颈动脉粥样硬化(atherosclerosis, AS)斑块形成的可能机制,为预防和治疗AS提供理论基础。方法:36只6周龄的雄性ApoE−/−小鼠随机分为6组(每组6只):blank组、NC组、miR-155 mimic组、miR-155 inhibitor组、miR-155 mimic and NC组、miR-155 mimic and P2X7R(-)组。利用PCR技术检测小鼠颈动脉斑块中miR-155的表达水平,HE染色显示颈动脉内膜,利用western blot技术检测P2X7R、NLRP3炎症小体相关蛋白、IL-1β表达水平。结果:与NC组相比,miR-155 mimic组中miR-155表达、P2X7R、NLRP3炎症小体相关蛋白以及IL-1β表达的升高有显著的统计学意义(P < 0.05),miR-155 inhibitor组则相反。miR-155 mimic and NC组与miR-155 mimic组中NLRP3炎症小体相关蛋白和IL-1β表达无明显差异,而miR-155 mimic and P2X7R(-)组的蛋白表达均明显减少(P < 0.05)。结论:在ApoE−/−小鼠中,miR-155可能通过调控P2X7R,激活NLRP3炎症小体,增强炎症反应,从而促进AS斑块的形成和发展。
Abstract: Objective: To explore the possible mechanism of microRNA-155 (miR-155) involved in the regulation of NLRP3 inflammasome mediated carotid atherosclerotic plaque formation in ApoE−/− mice, and to provide theoretical basis for the prevention and treatment of atherosclerosis. Methods: Thirty-six 6-week-old male ApoE−/− mice were randomly divided into six groups (6 in each group): blank group, NC group, miR-155 mimic group, miR-155 inhibitor group, miR-155 mimic and NC group, miR-155 mimic and P2X7R (-) group. The expression of miR-155 in carotid plaque of mice was detected by PCR. HE staining was used to show the intima of carotid artery. The expressions of P2X7R, NLRP3 inflammasome related proteins and IL-1β in plaque were detected by Western blot. Results: The expression of miR-155, P2X7R, NLRP3 inflammasome related proteins and IL-1β in miR-155 mimic group was significantly higher than that in NC group (P < 0.05). In miR-155 inhibitor group, it was the opposite. There was no significant difference in the expression of NLRP3 inflammasome related proteins and IL-1β between miR-155 mimic and NC group and miR-155 mimic group, but the protein expression of miR-155 mimic and P2X7R (-) group was significantly decreased (P < 0.05). Conclusion: In ApoE−/− mice, miR-155 may regulate P2X7R to activate NLRP3 inflammasome and enhance inflammatory response, thus promoting the formation and development of atherosclerotic plaque.
文章引用:彭晴, 尹瑞华, 朱晓岩, 马爱军, 潘旭东. MicroRNA-155通过P2X7R激活NLRP3炎性小体促进ApoE-/-小鼠颈动脉粥样硬化斑块的形成[J]. 临床医学进展, 2020, 10(10): 2348-2356. https://doi.org/10.12677/ACM.2020.1010354

参考文献

[1] Murray, C.J.L. and Lopez, A.D. (2013) Measuring the Global Burden of Disease. The New England Journal of Medicine, 369, 448-457. [Google Scholar] [CrossRef
[2] Simon, I.H., Amanuel, A.A., Kalkidan, H.A., et al. (2017) Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 333 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016. The Lancet, 390, 1260-1344. [Google Scholar] [CrossRef
[3] Hansson, G.K. and Hermansson, A. (2011) The Immune System in Atherosclerosis. Nature Immunology, 12, 204-212. [Google Scholar] [CrossRef] [PubMed]
[4] Libby, P., Lichtman, A.H. and Hansson, G.K. (2013) Immune Effector Mechanisms Implicated in Atherosclerosis: From Mice to Humans. Immunity, 38, 1092-1104. [Google Scholar] [CrossRef] [PubMed]
[5] Duewell, P., Kono, H., Rayner, K.J., et al. (2010) NLRP3 Inflammasomes Are Required for Atherogenesis and Activated by Cholesterol Crystals. Nature, 464, 1357-1361. [Google Scholar] [CrossRef] [PubMed]
[6] Baldrighi, M., Mallat, Z. and Li, X. (2017) NLRP3 Inflammasome Pathways in Atherosclerosis. Atherosclerosis, 267, 127-138. [Google Scholar] [CrossRef] [PubMed]
[7] Xiao, H., Lu, M., Lin, T.Y., et al. (2013) Sterol Regulatory Element Binding Protein 2 Activation of NLRP3 Inflammasome in Endothelium Mediates Hemodynamic-Induced Atherosclerosis Susceptibility. Circulation, 128, 632-642. [Google Scholar] [CrossRef
[8] Alena, G., Florian, H. and Eicke, L. (2018) NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis. Circulation Research, 122, 1722-1740. [Google Scholar] [CrossRef
[9] Zheng, F., Xing, S.S., Gong, Z.S., Xing, Q.C. (2013) NLRP3 Inflammasomes Show High Expression in Aorta of Patients with Atherosclerosis. Heart Lung & Circulation, 22, 746-750. [Google Scholar] [CrossRef] [PubMed]
[10] Varghese, G.P., Folkersen, L., Strawbridge, R.J., et al. (2016) NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis. Journal of the American Heart Association, 5, e003031. [Google Scholar] [CrossRef
[11] Virgilio, F.D., Ben, D.D., Sarti, A.C., et al. (2017) The P2X7 Receptor in Infection and Inflammation. Immunity, 47, 15-31. [Google Scholar] [CrossRef] [PubMed]
[12] Peng, K., Liu, L., Wei, D., et al. (2015) P2X7R Is Involved in the Progression of Atherosclerosis by Promoting NLRP3 Inflammasome Activation. International Journal of Molecular Medicine, 35, 1179-1188. [Google Scholar] [CrossRef] [PubMed]
[13] Faraoni, I., Antonetti, F.R., Cardone, J. and Bonmassar, E. (2009) miR-155 Gene: A Typical Multifunctional microRNA. Biochimica et Biophysica Acta, 1792, 497-505. [Google Scholar] [CrossRef] [PubMed]
[14] Yin, R.H., Zhu, X.Y., Wang, J., Yang, S.N., Ma, A.J., Xiao, Q., Song, J.Y. and Pan, X.D. (2019) MicroRNA-155 Promotes the Ox-LDL-Induced Activation of NLRP3 Inflammasomes via the ERK1/2 Pathway in THP-1 Macrophages and Aggravates Atherosclerosis in ApoE-/- Mice. Annals of Palliative Medicine, 8, 676-689. [Google Scholar] [CrossRef] [PubMed]
[15] Artlett, C.M., Sassi-Gaha, S., Hope, J.L., Feghali-Bostwick, C.A. and Katsikis, P.D. (2017) Mir-155 Is Overexpressed in Systemic Sclerosis Fibroblasts and Is Required for NLRP3 Inflammasome-Mediated Collagen Synthesis during Fibrosis. Annals of Palliative Medicine, 19, Article No. 144. [Google Scholar] [CrossRef] [PubMed]
[16] Luo, Q., Zeng, J.X., Li, W., Lin, L., Zhou, X., Tian, X., Liu, W.Y., Zhang, L.D. and Zhang, X.B. (2018) Silencing of miR-155 Suppresses Inflammatory Responses in Psoriasis through Inflammasome NLRP3 Regulation. International Journal of Molecular Medicine, 42, 1086-1095. [Google Scholar] [CrossRef] [PubMed]
[17] Chen, S., Smith, B. A. H., Iype, J., et al. (2015) MicroRNA-155-Deficient Dendritic Cells Cause Less Severe GVHD through Reduced Migration and Defective Inflammasome Activation. Blood, 126, 103-112. [Google Scholar] [CrossRef] [PubMed]
[18] Piscopiello, M., Sessa, M., Anzalone, N., et al. (2013) P2X7 Receptor Is Expressed in Human Vessels and Might Play a Role in Atherosclerosis. International Journal of Cardiology, 168, 2863-2866. [Google Scholar] [CrossRef] [PubMed]
[19] Lin, L., Huang, S.J., Zhu, Z.Y., Han, J.B., Wang, Z.X., Huang, W.J. and Huang, Z.Q. (2018) P2X7 Receptor Regulates EMMPRIN and MMP-9 Expression through AMPK/MAPK Signaling in PMA-Induced Macrophages. Molecular Medicine Reports, 18, 3027-3033. [Google Scholar] [CrossRef] [PubMed]
[20] Garcia-Martinez, I., Shaker, M.E. and Mehal, W.Z. (2015) Therapeutic Opportunities in Damage-Associated Molecular Pattern-Driven Metabolic Diseases. Antioxidants & Redox Signaling, 23, 1305-1315. [Google Scholar] [CrossRef] [PubMed]